TianYu Bio-Technology Co (SHSE:603717) Other Current Receivables: ¥180.8 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603717 TianYu Bio-Technology Co Ltd SHSE:603717
38 GF Score
Price ¥6.65
GF Value ¥6.02
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is TianYu Bio-Technology Co Other Current Receivables?

TianYu Bio-Technology Co SHSE:603717 -0.30% 38 Other Current Receivables is ¥180.8 Mil as of Jun. 2026. GuruFocus rates SHSE:603717 with a GF Score™ of 38/100 and a GF Value™ of ¥6.02 (Fairly Valued). The stock has 6 warning signs investors should review.

TianYu Bio-Technology Co's Other Current Receivables for the quarter that ended in Jun. 2026 was ¥180.8 Mil.

TianYu Bio-Technology Co's quarterly Other Current Receivables declined from Dec. 2025 (¥228.31 Mil) to Mar. 2026 (¥220.17 Mil) but then stayed the same from Mar. 2026 (¥220.17 Mil) to Jun. 2026 (¥180.77 Mil).

TianYu Bio-Technology Co's annual Other Current Receivables declined from Dec. 2023 (¥691.29 Mil) to Dec. 2024 (¥512.41 Mil) and declined from Dec. 2024 (¥512.41 Mil) to Dec. 2025 (¥228.31 Mil).

TianYu Bio-Technology Co Other Current Receivables Related Terms

TianYu Bio-Technology Co Other Current Receivables Historical Data

* Premium members only.

The historical data trend for TianYu Bio-Technology Co's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TianYu Bio-Technology Co Other Current Receivables Chart

TianYu Bio-Technology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 949.20 726.67 691.29 512.41 228.31

TianYu Bio-Technology Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 324.15 310.63 228.31 220.17 180.77
SHSE:603717
38GF Score
TianYu Bio-Technology Co Ltd SHSE:603717
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TianYu Bio-Technology Co Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of ¥180.8 Mil mean?
TianYu Bio-Technology Co (SHSE:603717) has a Other Current Receivables of ¥180.8 Mil as of Jun. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on TianYu Bio-Technology Co and its competitors.
Is TianYu Bio-Technology Co's Other Current Receivables too high?
TianYu Bio-Technology Co's current Other Current Receivables is ¥180.8 Mil. Overall, TianYu Bio-Technology Co has a GF Score™ of 38/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does TianYu Bio-Technology Co's Other Current Receivables compare to PWR and FIX?
TianYu Bio-Technology Co's Other Current Receivables of ¥180.8 Mil can be compared against companies in the Construction industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Construction company?
A good Other Current Receivables depends on the Construction industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on TianYu Bio-Technology Co and its competitors. TianYu Bio-Technology Co's current Other Current Receivables is ¥180.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TianYu Bio-Technology Co stock overvalued right now?
Based on GuruFocus' analysis, TianYu Bio-Technology Co (SHSE:603717) is currently considered Fairly Valued. The stock's GF Value™ is ¥6.02, compared to a current price of ¥6.65 — trading 10.5% above its estimated fair value. The current Other Current Receivables is ¥180.8 Mil. TianYu Bio-Technology Co's overall GF Score™ is 38/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For TianYu Bio-Technology Co (SHSE:603717), the current Other Current Receivables is ¥180.8 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TianYu Bio-Technology Co (SHSE:603717) Overvalued in 2026?

Based on GuruFocus' analysis, TianYu Bio-Technology Co stock appears to be overvalued. The current stock price of ¥6.65 is trading 10.5% above its estimated GF Value™ of ¥6.02. GuruFocus considers TianYu Bio-Technology Co to be Fairly Valued.

Key valuation signals for SHSE:603717:

  • Other Current Receivables: ¥180.8 Mil
  • GF Value™: ¥6.02 vs. price of ¥6.65 (10.5% above fair value)
  • GF Score™: 38/100 with 6 warning signs

No single metric tells the full story. See the SHSE:603717 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TianYu Bio-Technology Co Business Description

Address Lane 1688, Guoquan North Road, 2nd Floor, Building C4, Wangu Technology Park, Yangpu District, Shanghai, CHN, 200433
TianYu Bio-Technology Co Ltd is engaged in Garden ecological engineering business, ecological environment management and rural complex business, pig breeding business, production and marketing of agricultural products and cash crops.
38GF Score

Get the complete analysis for SHSE:603717

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥6.65
Price
¥6.02
GF Value